You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

metastatic pancreas cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Pancreatic Adenocarcinoma Trial in Baltimore (Epacadostat, Pembrolizumab, CRS-207)

Active, not recruiting
  • Metastatic Pancreatic Adenocarcinoma
  • Baltimore, Maryland
    The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Jan 3, 2023

Metastatic Pancreatic Adenocarcinoma Trial in Ann Arbor (Devimistat, Modified FOLFIRINOX)

Not yet recruiting
  • Metastatic Pancreatic Adenocarcinoma
  • Ann Arbor, Michigan
    Rogel Cancer Center
Jun 26, 2023

Cancer of Pancreas Trial in Cairo (Capecitabine, follow up)

Recruiting
  • Cancer of Pancreas
  • Cairo, Egypt
  • +2 more
Sep 30, 2022

Pancreatic Ductal Adenocarcinoma, Pancreas Adenocarcinoma, Pancreas Cancer Trial in Kansas City (Enfortumab vedotin)

Recruiting
  • Pancreatic Ductal Adenocarcinoma
  • +2 more
  • Enfortumab vedotin
  • Kansas City, Kansas
    University of Kansas Cancer Center
Jun 23, 2023

Metastatic Pancreatic Cancer Trial (FOLFIRINOX treatment)

Not yet recruiting
  • Metastatic Pancreatic Cancer
  • FOLFIRINOX treatment
  • (no location specified)
Aug 9, 2023

Cancer of Pancreas, Chemo Effect, Metastatic Pancreatic Cancer Trial in Shibin Al Kawm (Gemcitabine fluorouracil)

Completed
  • Cancer of Pancreas
  • +2 more
  • Gemcitabine fluorouracil
  • Shibīn Al Kawm, Menoufia, Egypt
    Menoufia University, Faculty of medicine
Aug 5, 2022

Adenocarcinoma of the Pancreas Trial in Miami (Durvalumab, Radiation Therapy)

Active, not recruiting
  • Adenocarcinoma of the Pancreas
  • Miami, Florida
    Miami Cancer Institute at Baptist Health, Inc.
Jul 7, 2022

Cancer Of Pancreas Trial (Analyze of GemCore status)

Not yet recruiting
  • Cancer Of Pancreas
  • Analyze of GemCore status
  • (no location specified)
Sep 19, 2023

KRAS Activating Mutation, Metastatic Cancer, Pancreas Cancer Trial in Saint Louis (avutometinib (VS-6766) and defactinib in

Recruiting
  • KRAS Activating Mutation
  • +4 more
  • avutometinib (VS-6766) and defactinib in combination with gemcitabine and nab-paclitaxel
  • Saint Louis, Missouri
    Washington University School of Medicine
Jan 3, 2023

Gastric Cancer, Colon Cancer, Pancreas Cancer Trial in Nanchang (CEA CAR-T cells)

Recruiting
  • Gastric Cancer
  • +6 more
  • CEA CAR-T cells
  • Nanchang, Jiangxi, China
    The First Affiliated Hospital of Nanchang University
Aug 23, 2023

Pancreatic Cancer, Adenocarcinoma of the Pancreas, Squamous Cell Carcinoma of Pancreas Trial in Boston (ZIMBERELIMAB,

Recruiting
  • Pancreatic Cancer
  • +3 more
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Jan 9, 2023

Pancreas Cancer, Pancreas Tumor, Pancreas Adenocarcinoma Trial (Laparoscopic surgical biopsy and organoid generation)

Not yet recruiting
  • Pancreas Cancer
  • +5 more
  • Laparoscopic surgical biopsy and organoid generation
  • (no location specified)
Apr 22, 2022

Pancreas Cancer Trial (Nivolumab, Irreversible electroporation (IRE))

Not yet recruiting
  • Pancreas Cancer
  • (no location specified)
Jun 27, 2022

Pancreas Cancer, Metastatic Pancreatic Cancer, Metastatic Pancreatic Adenocarcinoma Trial in Boston (drug, radiation, procedure)

Recruiting
  • Pancreas Cancer
  • +2 more
  • Boston, Massachusetts
    Massachusetts General Hospital Cancer Center
Aug 19, 2022

Pancreas Cancer Trial (surufatinib + camrelizumab + nab-paclitaxel + S-1, nab-paclitaxel + gemcitabine)

Recruiting
  • Pancreatic Cancer
  • +3 more
  • surufatinib + camrelizumab + nab-paclitaxel + S-1
  • nab-paclitaxel + gemcitabine
  • Beijing, China
    Chinese PLA General Hospital
Sep 26, 2022

Acinar Cell Adenocarcinoma of the Pancreas, Duct Cell Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer Trial in

Completed
  • Acinar Cell Adenocarcinoma of the Pancreas
  • +4 more
  • sorafenib tosylate
  • +4 more
  • Aurora, Colorado
  • +1 more
Sep 8, 2022

Viewpoints on Social Representations and Rationale Concerning

Terminated
  • Non-resectable Metastatic Cancer of the Lung
  • +7 more
  • Interviews
  • Questionnaires
  • Dijon, France
    Chu Dijon Bourogne
Apr 14, 2022

Metastatic Pancreatic Cancer, Adenocarcinoma of the Pancreas Trial in Weiden (nab-paclitaxel and gemcitabine, gemcitabine mono

Completed
  • Metastatic Pancreatic Cancer
  • Adenocarcinoma of the Pancreas
  • nab-paclitaxel and gemcitabine
  • gemcitabine mono and nab-paclitaxel and gemcitabine
  • Weiden, Germany
    Kliniken Nordoberpfalz AG, Klinikum Weiden
Nov 21, 2022

Cancer of Pancreas Trial in Dallas (Bemcentinib, Nab-paclitaxel, Gemcitabine)

Terminated
  • Cancer of Pancreas
  • Dallas, Texas
    University of Texas Southwestern Medical Center
Sep 26, 2022

Gadoxetate Sodium-Enhanced Magnetic Resonance Imaging When Used

Not yet recruiting
  • Metastatic Pancreatic Cancer
  • +2 more
  • EOB-MRI
  • +2 more
  • Multiple Locations, Japan
    Many locations
Oct 24, 2023

Cancer, Solid Tumor, Colorectal Cancer Trial (biological, radiation, drug)

Not yet recruiting
  • Cancer
  • +8 more
  • DK210 (EGFR)
  • +3 more
  • (no location specified)
Jan 27, 2023

Advanced or Metastatic Solid Tumors, Breast Cancer, Ovarian Cancer Trial in Houston (IDE-161)

Not yet recruiting
  • Advanced or Metastatic Solid Tumors
  • +4 more
  • Houston, Texas
    MD Anderson
Mar 27, 2023

Pancreatic Ductal Adenocarcinoma, Metastatic Pancreatic Cancer, Circulating Tumor Cell Trial in Montpellier (Detection of

Recruiting
  • Pancreatic Ductal Adenocarcinoma
  • +2 more
  • Detection of circulating tumor cells expressing Axl: CTC-AXL(+)
  • Montpellier, France
    CHU Montpellier
Jul 1, 2022

Pancreatic Cancer Trial in Lexington (Cabozantinib, Pembrolizumab)

Recruiting
  • Pancreatic Cancer
  • Lexington, Kentucky
    University of Kentucky Markey Cancer Center
Feb 26, 2022

Histologically or Cytologically Confirmed Pancreatic Cancer, Unresectable or Borderline Resectable Pancreatic Cancer, Pancreatic

Terminated
Has Results
  • Histologically or Cytologically Confirmed Pancreatic Cancer
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Apr 19, 2022